CureMatch Releases Research on Individualized Cancer Therapy Matching
CureMatch, Inc., a leader in precision medicine digital decision support solutions, along with authors from esteemed healthcare organizations, released an abstract presenting new research on groundbreaking artificial intelligence (AI) technology for individualized cancer treatment for the 2021 ASCO Annual Meeting, held online June 4-8, 2021.
The abstract is titled, “Significance of Scores Generated by a Cancer Therapy Matching Engine for Patient Outcomes.” The study assessed the efficacy of an AI-based molecular therapy matching tool….Read More